메뉴 건너뛰기
Gastroenterologe
Volumn 2, Issue 1, 2007, Pages 6-11
Epidemiology, diagnosis and prevention;Epidemiologie, diagnostik und prävention
Author keywords

Hemochromatosis; Hepatocellular carcinoma; IFN ; Non alcohol based steatohepatitis; Viral hepatitis
Indexed keywords

EID: 33846397030     PISSN: 18619681     EISSN: 1861969X     Source Type: Journal    
DOI: 10.1007/s11377-006-0060-7     Document Type: Article
Times cited : (4)
References (14)
  • 1
    • 7044229778 scopus 로고    scopus 로고
    • Primary liver cancer: Worldwide incidence and trends
    • Bosch FX, Ribes J, Diaz M et al. (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16
    • (2004) Gastroenterology , vol.127
    • Bosch, F.X.1    Ribes, J.2    Diaz, M.3
  • 3
    • 0842321807 scopus 로고    scopus 로고
    • Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
    • El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126: 460-468
    • (2004) Gastroenterology , vol.126 , pp. 460-468
    • El-Serag, H.B.1    Tran, T.2    Everhart, J.E.3
  • 4
    • 0034544613 scopus 로고    scopus 로고
    • How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system
    • Farinati F, Rinaldi M, Gianni S et al. (2000) How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 89: 2266-2273
    • (2000) Cancer , vol.89 , pp. 2266-2273
    • Farinati, F.1    Rinaldi, M.2    Gianni, S.3
  • 5
    • 7044263003 scopus 로고    scopus 로고
    • Prevention of Hepatitis C virus-related hepatocellular carcinoma
    • Heathcote EJ (2004) Prevention of Hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 127: S294-302
    • (2004) Gastroenterology , vol.127
    • Heathcote, E.J.1
  • 6
    • 10644225254 scopus 로고    scopus 로고
    • Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score
    • Kudo M, Chung H, Haji S et al. (2004) Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 40: 1396-1405
    • (2004) Hepatology , vol.40 , pp. 1396-1405
    • Kudo, M.1    Chung, H.2    Haji, S.3
  • 7
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: The BCLC staging classification
    • Llovet JM, Bru C, Bruix J. (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19: 329-338
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Bru, C.2    Bruix, J.3
  • 8
    • 1242307263 scopus 로고    scopus 로고
    • The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinoma
    • Llovet JM, Fuster J, Bruix J. (2004) The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 10: S115-120
    • (2004) Liver Transpl , vol.10
    • Llovet, J.M.1    Fuster, J.2    Bruix, J.3
  • 9
    • 7044241059 scopus 로고    scopus 로고
    • Prevention of Hepatitis B virus-related hepatocellular carcinoma
    • Lok AS. (2004) Prevention of Hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 127: S303-309
    • (2004) Gastroenterology , vol.127
    • Lok, A.S.1
  • 10
    • 12444285909 scopus 로고    scopus 로고
    • Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
    • Marrero JA, Fontana RJ, Fu S et al. (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42: 218-224
    • (2005) J Hepatol , vol.42 , pp. 218-224
    • Marrero, J.A.1    Fontana, R.J.2    Fu, S.3
  • 11
    • 1842426695 scopus 로고    scopus 로고
    • Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance
    • Sangiovanni A, Del Ninno E, Fasani P et al. (2004) Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126: 1005-1014
    • (2004) Gastroenterology , vol.126 , pp. 1005-1014
    • Sangiovanni, A.1    Del Ninno, E.2    Fasani, P.3
  • 12
    • 19944432263 scopus 로고    scopus 로고
    • Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
    • Schiffer E, Housset C, Cacheux W et al. (2005) Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 41: 307-314
    • (2005) Hepatology , vol.41 , pp. 307-314
    • Schiffer, E.1    Housset, C.2    Cacheux, W.3
  • 13
    • 7044263067 scopus 로고    scopus 로고
    • Diagnosis and staging of hepatocellular carcinoma
    • Talwalkar JA, Gores GJ. (2004) Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 127: S126-132
    • (2004) Gastroenterology , vol.127
    • Talwalkar, J.A.1    Gores, G.J.2
  • 14
    • 0037369657 scopus 로고    scopus 로고
    • Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
    • Velazquez RF, Rodriguez M, Navascues CA et al. (2003) Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37: 520-527
    • (2003) Hepatology , vol.37 , pp. 520-527
    • Velazquez, R.F.1    Rodriguez, M.2    Navascues, C.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.